Skip to main content
editorial
. 2021 Jul;69(7):1643–1644. doi: 10.4103/ijo.IJO_1611_21

Table 1.

Four groups of uveal melanoma based on The Cancer Genome Atlas classification[15,16]

Group Genetic/molecular Profile Prognosis
Group A mRNA class 1, infrequent chromosomal aberrations, disomy 3, extra 6p, normal 8q, no inflammation Favorable
Group B mRNA class 1, infrequent chromosomal aberrations, disomy 3, extra 6p, partial extra 8q, no inflammation Less favorable
Group C mRNA class 2, frequent chromosomal aberrations, monosomy 3, extra 8q, some inflammation Unfavorable
Group D mRNA class 2, frequent chromosomal aberrations, monosomy 3, >>extra 8q, severe inflammation Unfavorable

Adapted from Jager MJ, Brouwer NJ, Esmaeli B. The Cancer Genome Atlas Project: an integrated molecular view of uveal melanoma. Ophthalmology. 2018;125:1139-1142